Recent News

ERYTECH to Present at Cowen and Company 40th Annual Health Care Conference
February 26, 2020
LYON, France and CAMBRIDGE, Mass. , Feb. 26, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that Gil Beyen ,
ERYTECH Enters Into Strategic Supply Partnership with the German Red Cross Blood Donor Service
February 20, 2020
Second European source of donor red blood cells secured in preparation for expanded production of red blood cell-based therapeutics LYON, France and CAMBRIDGE, Mass. , Feb. 20, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company